Small Drug Makers Protest India’s New License-Centralizing Proposal
This article was originally published in PharmAsia News
Executive Summary
India's 5,000 small companies that make pharmaceuticals are challenging a government proposal to centralize the granting of manufacturing licenses, an authority now held by each state. The drug makers fear additional expenses and rules to get clearance. The head of India's Small Pharma Industry Confederation said proposed legislation is written in favor of multinational drug makers. Small firms cannot incur such huge costs, he said, asserting the responsibility should remain at the state level. (Click here for more